Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Pediatr Blood Cancer. 2015 Mar 23;62(7):1214–1221. doi: 10.1002/pbc.25474

Figure 4.

Figure 4

(A) Relationship between caveolin-1 immunohistochemical staining intensity (H Score) and response. PD1/PD2 (progressive disease, as defined in Supplemental Respose Definitions). PR partial response (>50% volume regression); CR (complete response with regrowth during 6 weeks; MCR, CR maintained at week 6. Bars indicate the mean H score for the group. (B) Relationship between caveolin-1 and SPARC gene expression (Agilent Sureprint 3 arrays) and response. Non-repoders (PD1/PD2); Responders (PR/CR/MCR). Progressive disease, as defined in Supplemental Respose Definitions). PR, partial response; CR (complete response with regrowth during 6 weeks); MCR, CR maintained at week 6.